{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:53:14Z","timestamp":1784227994852,"version":"3.55.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1053\/j.semnuclmed.2024.02.004","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T22:14:51Z","timestamp":1710281691000},"page":"701-716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Imaging of Cardiac Sarcoidosis: An Update and Future Aspects"],"prefix":"10.1053","volume":"54","author":[{"given":"Petar","family":"Saric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Giudicessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9202-0233","authenticated-orcid":false,"given":"Andrew N.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-0949","authenticated-orcid":false,"given":"Joanna E.","family":"Kusmirek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panithaya","family":"Chareonthaitawee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0001","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0002","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cpet.2018.12.004","article-title":"PET\/CT evaluation of cardiac sarcoidosis","volume":"14","author":"Bois","year":"2019","journal-title":"PET Clin"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0003","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1513\/AnnalsATS.201508-568BC","article-title":"Epidemiology of sarcoidosis in a prospective cohort study of U.S. women","volume":"13","author":"Dumas","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0004","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.rmed.2012.02.007","article-title":"Unexpectedly high prevalence of sarcoidosis in a representative U.S. metropolitan population","volume":"106","author":"Erdal","year":"2012","journal-title":"Respir Med"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ccm.2006.04.002","article-title":"Racial and ethnic disparities in sarcoidosis: From genetics to socioeconomics","volume":"27","author":"Westney","year":"2006","journal-title":"Clin Chest Med"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0006","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","article-title":"Clinicopathological study of fatal myocardial sarcoidosis","volume":"278","author":"Matsui","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0007","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0008","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/hrt.2005.080481","article-title":"Cardiac sarcoidosis","volume":"92","author":"Doughan","year":"2006","journal-title":"Heart"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0009","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0010","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/bmj.292.6528.1095","article-title":"Sarcoid heart disease","volume":"292","author":"Fleming","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0011","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11)","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0012","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1378\/chest.128.1.30","article-title":"Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands","volume":"128","author":"Smedema","year":"2005","journal-title":"Chest"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0013","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0014","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/europace\/eun110","article-title":"Ventricular tachyarrhythmia as a primary presentation of sarcoidosis","volume":"10","author":"Uusimaa","year":"2008","journal-title":"Europace"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0015","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11886-014-0514-3","article-title":"Cardiac sarcoidosis","volume":"16","author":"Zipse","year":"2014","journal-title":"Curr Cardiol Rep"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0016","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0017","first-page":"89","article-title":"Diagnostic standard and guidelines for sarcoidosis","volume":"27","author":"Hiraga","year":"2007","journal-title":"Jpn J Sarcoid Granul Disord."},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0018","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann Nuc Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0019","doi-asserted-by":"crossref","first-page":"121","DOI":"10.17996\/anc.17-00029","article-title":"Japanese guidelines for cardiac sarcoidosis","volume":"3","author":"Yoshinaga","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.05.2011.4278","article-title":"Systemic sarcoidosis with caseating granuloma","volume":"2012","author":"Binesh","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0021","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-012-9358-3","article-title":"Idiopathic giant cell myocarditis and cardiac sarcoidosis","volume":"18","author":"Blauwet","year":"2013","journal-title":"Heart Fail Rev"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0022","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0023","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2021.04.022","article-title":"Identification of a novel presumed cardiac sarcoidosis category for patients at high risk of disease","volume":"335","author":"Rosenbaum","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0024","article-title":"The role of echocardiography in the contemporary diagnosis and prognosis of cardiac sarcoidosis: A comprehensive review","volume":"13","author":"Okafor","year":"2023","journal-title":"Life-Basel"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0025","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jce.15191","article-title":"Electrogram-guided endomyocardial biopsy yield in patients with suspected cardiac sarcoidosis and relation to outcomes","volume":"32","author":"Ezzeddine","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0026","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: Epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0027","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/heartjnl-2019-316442","article-title":"Cardiac sarcoidosis: state-of-the-art review","volume":"107","author":"Kouranos","year":"2021","journal-title":"Heart"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0028","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: Expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0029","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0030","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0002-9149(89)90323-8","article-title":"Two-dimensional echocardiographic findings in systemic sarcoidosis","volume":"63","author":"Burstow","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0031","first-page":"215","article-title":"A proposal for diagnostic criteria of basal thinning of the ventricular septum in cardiac sarcoidosis: A multicenter study","volume":"70","author":"Morimoto","year":"2006","journal-title":"Circ J"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0032","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11886-018-1065-9","article-title":"Echocardiography in sarcoidosis","volume":"20","author":"Kurmann","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0033","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1093\/eurheartj\/ehac323","article-title":"Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry","volume":"43","author":"Nabeta","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0034","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amjcard.2023.01.002","article-title":"The mechanism and natural history of mitral regurgitation in cardiac sarcoidosis","volume":"191","author":"Sykora","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1378\/chest.66.4.452","article-title":"Myocardial sarcoidosis presenting as acute mitral insufficiency","volume":"66","author":"Zoneraich","year":"1974","journal-title":"Chest"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0036","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12471-016-0847-1","article-title":"Pulmonary hypertension complicating pulmonary sarcoidosis","volume":"24","author":"Huitema","year":"2016","journal-title":"Neth Heart J"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0037","first-page":"949","article-title":"Advances in imaging for diagnosis and management of cardiac sarcoidosis","volume":"16","author":"Aggarwal","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0038","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ijcard.2016.10.073","article-title":"Early detection of cardiac involvement in sarcoidosis with 2-dimensional speckle-tracking echocardiography","volume":"227","author":"Schouver","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0039","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014091","article-title":"Clinical utilization of multimodality imaging for myocarditis and cardiac sarcoidosis","volume":"16","author":"Chareonthaitawee","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0041","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12947-019-0176-9","article-title":"Myocardial tissue characterisation using echocardiographic deformation imaging","volume":"17","author":"Moharram","year":"2019","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0042","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ejhf.205","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis","volume":"17","author":"Joyce","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0043","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12872-019-01323-0","article-title":"Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis","volume":"20","author":"Di Stefano","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0044","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/ehjci\/jez235","article-title":"Deterioration of biventricular strain is an early marker of cardiac involvement in confirmed sarcoidosis","volume":"21","author":"Kusunose","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10554-017-1233-9","article-title":"Myocardial contractile patterns predict future cardiac events in sarcoidosis","volume":"34","author":"Chen","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0046","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1111\/echo.14886","article-title":"Speckle tracking echocardiography can predict subclinical myocardial involvement in patients with sarcoidosis: A meta-analysis","volume":"37","author":"Barssoum","year":"2020","journal-title":"Echocardiography"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0047","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1093\/ejechocard\/jer184","article-title":"Response to steroid therapy in cardiac sarcoidosis: insights from myocardial strain","volume":"13","author":"Lo","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0048","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00408-015-9748-0","article-title":"Early detection of Bi-ventricular and atrial mechanical dysfunction using two-dimensional speckle tracking echocardiography in patients with sarcoidosis","volume":"193","author":"Tigen","year":"2015","journal-title":"Lung"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0049","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/crj.12307","article-title":"Myocardial deformation and total atrial conduction time in the prediction of cardiac involvement in patients with pulmonary sarcoidosis","volume":"11","author":"Degirmenci","year":"2017","journal-title":"Clin Respir J"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1148\/rg.241035076","article-title":"Radiologic manifestations of sarcoidosis in various organs","volume":"24","author":"Koyama","year":"2004","journal-title":"Radiographics"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0051","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0052","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0053","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12350-019-01746-4","article-title":"Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol","volume":"28","author":"Christopoulos","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0054","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s12350-019-01786-w","article-title":"Characterization of a highly effective preparation for suppression of myocardial glucose utilization","volume":"27","author":"Larson","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0056","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2125.1979.tb01000.x","article-title":"A dose-response study of the anticoagulant and lipolytic activities of heparin in normal subjects","volume":"7","author":"Asmal","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0057","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2967\/jnumed.121.261981","article-title":"Comparison of the effect of three different dietary modifications on myocardial suppression in (18)F-Fdg Pet\/Ct evaluation of patients for suspected cardiac sarcoidosis","volume":"62","author":"Ozutemiz","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0058","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00259-022-06062-7","article-title":"The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies","volume":"50","author":"Alfawara","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0059","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s12350-023-03209-3","article-title":"Utility of serum ketone levels for assessment of myocardial glucose suppression for (18)F-fluorodeoxyglucose PET in patients referred for evaluation of endocarditis","volume":"30","author":"Madamanchi","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0060","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0061","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-020-02201-5","article-title":"Quantitative assessment of cardiac hypermetabolism and perfusion for diagnosis of cardiac sarcoidosis","volume":"29","author":"Miller","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0062","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jcmg.2020.11.016","article-title":"Pre-treatment myocardial (18)FDG uptake predicts response to immunosuppression in patients with cardiac sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0063","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0064","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic impact of extent, severity, and heterogeneity of abnormalities on (18)F-FDG PET scans for suspected cardiac sarcoidosis","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0065","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0066","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0067","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of (18)F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0068","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cardfail.2019.02.018","article-title":"Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis","volume":"25","author":"Ning","year":"2019","journal-title":"J Cardiac Fail"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0069","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0284185115600916","article-title":"Administration of unfractionated heparin with prolonged fasting could reduce physiological 18F-fluorodeoxyglucose uptake in the heart","volume":"57","author":"Masuda","year":"2016","journal-title":"Acta Radiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12350-018-1356-y","article-title":"Emerging imaging targets for infiltrative cardiomyopathy: Inflammation and fibrosis","volume":"26","author":"Bengel","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0071","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3390\/ph14121286","article-title":"PET imaging in cardiac sarcoidosis: A narrative review with focus on novel PET tracers","volume":"14","author":"Saric","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0072","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s12094-021-02734-2","article-title":"Cancer-associated fibroblasts in colorectal cancer","volume":"24","author":"Kamali Zonouzi","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0073","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/biomedicines9020212","article-title":"Imaging inflammation with positron emission tomography","volume":"9","author":"Iking","year":"2021","journal-title":"Biomedicines"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0074","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40336-023-00548-6","article-title":"A spotlight on fibroblast-activated protein inhibitor (FAPi) cardiovascular imaging","volume":"11","author":"Caobelli","year":"2023","journal-title":"Clin Transl Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188479","article-title":"Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography","volume":"12","author":"Aoyama","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0076","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s12350-023-03243-1","article-title":"Extensive cardiac FDG uptake in a patient with AL amyloidosis","volume":"30","author":"Hatipoglu","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0077","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2018.10.083","article-title":"Prevalence of 18F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"284","author":"Protonotarios","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0078","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004316","article-title":"Prospective evaluation of 18F-Fluorodeoxyglucose uptake in postischemic myocardium by simultaneous positron emission tomography\/magnetic resonance imaging as a prognostic marker of functional outcome","volume":"9","author":"Rischpler","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0079","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s12350-021-02886-2","article-title":"18)F-FDG\/(13)N-ammonia cardiac PET findings in ATTR cardiac amyloidosis","volume":"30","author":"Young","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jacc.2022.10.021","article-title":"Genetic cardiomyopathy masquerading as cardiac sarcoidosis","volume":"81","author":"Lal","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0081","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCGEN.123.004099","article-title":"Cardiac sarcoidosis mimickers: Genetic testing in undifferentiated inflammatory cardiomyopathies","volume":"16","author":"Castrichini","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0082","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0083","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0084","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7457369","article-title":"Cardiac magnetic resonance imaging for diagnosis of cardiac sarcoidosis: A meta-analysis","volume":"2018","author":"Zhang","year":"2018","journal-title":"Can Respir J"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0085","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0086","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001728","article-title":"T2-weighted short-tau-inversion-recovery imaging reflects disease activity of cardiac sarcoidosis","volume":"8","author":"Tonegawa-Kuji","year":"2021","journal-title":"Open Heart"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0087","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0088","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCRESAHA.116.307974","article-title":"T1 mapping in characterizing myocardial disease: A comprehensive review","volume":"119","author":"Puntmann","year":"2016","journal-title":"Circ Res"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0089","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12968-023-00918-z","article-title":"Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: A cardiovascular magnetic resonance study","volume":"25","author":"Treiber","year":"2023","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1148\/radiol.2017162732","article-title":"T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis","volume":"285","author":"Puntmann","year":"2017","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0091","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/jim-2016-000144","article-title":"Resolution of abnormal cardiac MRI T2 signal following immune suppression for cardiac sarcoidosis","volume":"64","author":"Crouser","year":"2016","journal-title":"J Investig Med"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0092","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.113.000867","article-title":"Evaluation of known or suspected cardiac sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0093","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jcmg.2022.10.018","article-title":"Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis","volume":"16","author":"Stevenson","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0094","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jcmg.2022.11.012","article-title":"Prognostic value of RV abnormalities on CMR in patients with known or suspected cardiac sarcoidosis","volume":"16","author":"Wang","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0095","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222483","article-title":"Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: A systematic review and meta-analysis","volume":"307","author":"Aitken","year":"2023","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0096","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0097","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1378\/chest.122.6.1895","article-title":"Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: A 1-year follow-up study","volume":"122","author":"Vignaux","year":"2002","journal-title":"Chest"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0098","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","article-title":"Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis","volume":"100","author":"Ise","year":"2014","journal-title":"Heart"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0099","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.2967\/jnumed.111.092726","article-title":"Performance measurements of the Siemens mMR integrated whole-body PET\/MR scanner","volume":"52","author":"Delso","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccl.2015.08.002","article-title":"Cardiovascular PET\/MRI: Challenges and opportunities","volume":"34","author":"LaForest","year":"2016","journal-title":"Cardiol Clin"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0101","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.semnuclmed.2012.08.007","article-title":"Magnetic resonance-based motion correction for positron emission tomography imaging","volume":"43","author":"Ouyang","year":"2013","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0102","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s12350-015-0197-1","article-title":"Evaluation of attenuation correction in cardiac PET using PET\/MR","volume":"24","author":"Lau","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0103","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0104","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12350-020-02359-y","article-title":"Diagnostic utility of fusion (18)F-fluorodeoxyglucose positron emission tomography\/cardiac magnetic resonance imaging in cardiac sarcoidosis","volume":"29","author":"Okune","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41824-021-00119-w","article-title":"Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis","volume":"5","author":"Cheung","year":"2021","journal-title":"Eur J Hybrid Imag"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0106","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12410-013-9213-5","article-title":"State of the art in cardiac hybrid technology: PET\/MR","volume":"6","author":"Nappi","year":"2013","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0107","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1183\/09031936.00088612","article-title":"Imaging the inflammatory activity of sarcoidosis","volume":"41","author":"Keijsers","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0108","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000047316","article-title":"Technetium-99m sestamibi\/tetrofosmin myocardial perfusion scanning in cardiac and noncardiac sarcoidosis","volume":"94","author":"Eguchi","year":"2000","journal-title":"Cardiology"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0109","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1378\/chest.126.4.1372","article-title":"Usefulness of dual 67Ga and 99mTc-sestamibi single-photon-emission CT scanning in the diagnosis of cardiac sarcoidosis","volume":"126","author":"Nakazawa","year":"2004","journal-title":"Chest"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2019.10.003","article-title":"Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)","volume":"220","author":"Birnie","year":"2020","journal-title":"Am Heart J"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0111","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0112","first-page":"445","article-title":"Hybrid cardiac magnetic resonance\/fluorodeoxyglucose positron emission tomography to differentiate active from chronic cardiac sarcoidosis","volume":"15","author":"Greulich","year":"2022","journal-title":"Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0113","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1161\/CIRCULATIONAHA.112.001217","article-title":"Active cardiac sarcoidosis: First clinical experience of simultaneous positron emission tomography\u2013magnetic resonance imaging for the diagnosis of cardiac disease","volume":"127","author":"White","year":"2013","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0114","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1253\/circj.CJ-21-0265","article-title":"Deep learning algorithm to detect cardiac sarcoidosis from echocardiographic movies","volume":"86","author":"Katsushika","year":"2021","journal-title":"Circ J"},{"key":"10.1053\/j.semnuclmed.2024.02.004_bib0115","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s10554-022-02564-5","article-title":"Predicting adverse cardiac events in sarcoidosis: Deep learning from automated characterization of regional myocardial remodeling","volume":"38","author":"Lu","year":"2022","journal-title":"Int J Cardiovasc Imaging"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299824000163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299824000163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T12:55:21Z","timestamp":1723812921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299824000163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0001299824000163"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2024.02.004","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging of Cardiac Sarcoidosis: An Update and Future Aspects","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2024.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}